New Mass Photometer Promises to Significantly Improve AAV Workflows
New SamuxMP mass photometer dramatically improves the efficiency of adeno-associated-virus characterization
Therapeutics
Codex DNA Releases Long Gene Fragment Cloning on the BioXp™ System
Automated synthesis of gene fragments using the BioXp™ system enables overnight production of error-corrected, de novo synthetic genes of up to 7,200 base pairs in length
Single-Cell Proteomic Pathway Omics
Identifying adaptive signaling pathways for designing improved targeted therapies
Thermo Fisher Scientific Launches First T-Cell Medium Designed Specifically for Allogeneic Cell Therapy Workflows
Novel media supports automated T-cell expansion to deliver scalable, cost-effective cell therapy treatments
Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research
The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks
Future-Proof Your HCP Strategy
Robust and accurate HCP measurement is crucial throughout biologics development
Challenging Host Cell Protein Assays
FAQs about improving risk mitigation by challenging host cell protein assays
Host Cell Protein Control Solutions
Find solutions, expertise, and support to advance and accelerate therapeutics
Don't Leave Antibody Performance to Chance
Antibody validation and quality control strategies ensure high specificity and reproducibility for optimal performance
Recent Developments in Proteolysis Targeting Chimeras
In this Q&A, Craig Crews, PhD, discusses the discovery and development of proteolysis targeting chimeras, a new modality that is being explored for both drug discovery and therapeutic application